Impact of Population Pharmacokinetic- Pharmacodynamic Analyses on the Drug Development Process: Experience at Parke-Davis

Author： Olson S.C. Bockbrader H. Boyd R.A. Cook J. Koup J.R. Lalonde R.L. Siedlik P.H. Powell J.R.

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.38, Iss.5, 2000-05, pp. : 449-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics, Drug Interactions and Exposure-Response Relationship of Eslicarbazepine Acetate in Adult Patients with Partial-Onset Seizures: Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses

By Falcão Amilcar Fuseau Eliane

CNS Drugs, Vol. 26, Iss. 1, 2012-01 ,pp. : 79-91

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

By Yang Bing-Bing Lum Peggy Chen Alin Arends Rosalin Roskos Lorin Smith Brian Ruixo Juan José Pérez

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 729-740

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies

By Meibohm Bernd

Clinical Pharmacokinetics, Vol. 50, Iss. 12, 2011-12 ,pp. : 823-824

Adis International

Access to resources Recommend Favorite

Bayesian Population Pharmacokinetic and Pharmacodynamic Analyses Using Mixture Models

By Rosner Gary L. Müller Peter

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 2, 1997-04 ,pp. : 209-233

Springer Publishing Company

Access to resources Recommend Favorite

Development of Biosimilars—Pharmacokinetic and Pharmacodynamic Considerations

By Wang Yow-Ming Chow Andrew

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 46-61

Taylor & Francis Ltd

Access to resources Recommend Favorite